Major Breakthrough for Sufferers of Common Eye Disease

Sufferers of common eye disease - ‘dry Age-Related Macular Degeneration (AMD)’ who end with total blindness can now find novel therapies that will benefit them.

Breakthrough with important implications for sufferers of dry Age-Related Macular Degeneration (AMD), a common blinding eye disease, is the regulation of the integrity of the retina’s blood vessels.

Scientists at Trinity College Dublin //have announced a major breakthrough with important implications for sufferers of a common eye disease - dry Age-Related Macular Degeneration (AMD) - which can cause total blindness in sufferers, and for which there are currently no approved therapies.

Age Related Macular Degeneration (AMD) - Causes, Symptoms, Diagnosis, Treatment & Prevention
Age related macular degeneration is a disease of the elderly, wherein the macula or the central part of the retina gets affected, leading to loss of vision.

‘Novel targets for AMD therapy have been discovered, which involve the regulation of the dysfunction of blood vessels of the retina to prevent the development of dry AMD.’
Read More..

The scientists discovered that a key component of the cells lining the retinal blood vessels, namely claudin-5, may be central to the development of the common blinding eye disease, AMD. In pre-clinical models, it was discovered that "leaky blood vessels" pre-disposed the eye to developing features of AMD.

"We were initially surprised that these blood vessels of the inner retina contributed to an AMD-like pathology, however it now appears that their dysfunction may represent one of the earliest initiating factors of the disease," said Dr Natalie Hudson, Post-doctoral researcher at Trinity, and first author of the study.

Age-Related Macular Degeneration (AMD)

Foods that Give You Sparkling Eyes
Food not only sustains us but the kind and quality of food determines the state of your health, which includes your eyes. Let us see which foods can bring a sparkle to your eyes!

AMD is the most common form of central retinal blindness in the aging population. The disease involves a loss of central visual acuity, such that everyday tasks such as reading, watching TV, driving, or using computers become difficult and in some cases impossible.

There are two forms of AMD: ’dry’ and ’wet’. While therapies are available for the management of wet AMD, there are no treatments, therapies or cures yet approved for dry AMD, which accounts for the majority of cases in Ireland and worldwide.

Dry Age-related Macular Degeneration: New Insights
Effective communication by health professionals may be key to reducing the psychological impact of 'dry' age-related macular degeneration diagnosis, suggests study

Patients living with dry AMD are presently recommended to pursue lifestyle changes, such as stopping smoking, and improving diet and exercise regimes. Novel forms of therapy are desperately needed in an ever-aging society, with life expectancy currently far exceeding the rate of development of drugs for aging associated conditions.

Dr Matthew Campbell, Assistant Professor in Genetics at Trinity, said: "Identifying the early molecular events that cause dry AMD will allow us to develop a targeted approach to therapy. In this case, we believe that regulating the integrity of the retina’s blood vessels may, over time, help to prevent the development of dry AMD."

New, Easy Treatment for Age Related Macular Degeneration Shows Promise
Patients with age-related macular degeneration may soon see their monthly injection become an annual refill, with potentially better results.

Dr Mark Cahill, consultant Ophthalmologist at the Royal Victoria Eye and Ear Hospital (RVEEH), added. "Our findings have highlighted the power of basic and clinical research working towards identifying novel targets for AMD therapy, which will ultimately benefit patients in the future."

Source-Eurekalert